🔗 Share this article

An underground economy for unapproved weight-loss medications is being driven by social media fitness personalities and vendors on communication apps, according to recent findings.

Investigational Drug Acquiring Popularity Via Social Media

Retatrutide, which remains in clinical trials, is being promoted by online personalities for its supposed weight-reducing effects. Followers are encouraged to message these accounts directly for supplier links, while also receiving discount codes.

Thriving Trade on Social Networks

Separately, a robust market exists on messaging services, where communities with thousands of participants share comparison images, injection guides and claims of next-day UK delivery. Sellers market the substance there before redirecting customers to other platforms for purchases.

Learning About Retatrutide

This medication is an experimental injection created by US drugmaker Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies suggest it could help individuals lose up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being promoted online as the successor to Ozempic.

Medical Professionals Voice Concerns

Nevertheless, doctors and pharmacists have warned that the distribution of what remains an unlicensed drug in the UK is worrisome and could lead to users injecting substances of uncertain source.

Some experts said the demand for retatrutide could be connected to the increasing cost of licensed weight loss products such as Mounjaro.

Legal Position and Enforcement

Selling the unapproved drug on TikTok or messaging apps is illegal in the United Kingdom, as it is an unlicensed medication that cannot be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Some content creators try to circumvent the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and distribution can still violate pharmaceutical, advertising, and customer laws, risking penalties, legal action or imprisonment.

Platform Response and Content Removal

According to the social media company, the platform has removed problematic content and banned associated keywords and search suggestions. The organization said it was committed to keeping the service secure and allocating resources in strengthening enforcement strategies.

Digital Marketplace Activities

Investigations also found communities with up to nine thousand members selling retatrutide using Telegram's integrated search feature, which operates like a public directory. Entering “retatrutide” immediately displays groups with thousands of members, filled with photos of weight loss, positive testimonials and detailed guides for preparing or administering at home.

Within moments of joining one group, a seller posted WhatsApp details, where most purchases take place. The seller sent an instruction manual and promised delivery within two days. When asked whether the substance was genuine, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one inquired about body mass, medical conditions or previous experience.

Item Details and Costs

Within these groups, posts display dark colored parcels with postal service stickers, stating to include fresh supplies. One communication read: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at home with purified liquid, or ready-to-use injectors typically priced at £160 for 20 milligrams. When questioned how long a injector should last, vendors give conflicting answers varying between a several days to “depends on your body”.

Platform Oversight and Safety Measures

A representative for Telegram stated it actively moderated dangerous material on its service including material that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Warnings

“People are administering substances they can’t verify. Although the science behind this drug is sound, these online products may not contain what they claim,” said a pharmacy expert, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the increase in demand to recent price rises for authorized weight-loss medications such as Mounjaro. “With costs increasing, patients are using social media. But counterfeit treatments are highly risky. You can’t be certain what’s contained or whether the environment they were made in was sterile,” she explained.

Her team has already encountered patients injured by personal administration from unconfirmed suppliers. “We understand the disappointment, but purchasing from messaging apps or communication platforms is taking chances with your well-being,” said the doctor. “These substances could be contaminated or improperly measured.”

Producer Statement

A spokesperson from the pharmaceutical company said the substance was in third stage research studies and had not been reviewed or authorized by any regulatory agency globally. “Consequently at this point no one can sell [it] for personal consumption,” they explained, adding that any item “falsely representing itself as a company experimental substance not yet authorized … may subject users to potentially significant health risks”.